Abdel‐Rahman N Zekri
Biographic Data
| ID | 8430383 |
|---|---|
| NAME | Abdel‐Rahman N Zekri |
| GIVEN NAMES | Abdel‐Rahman N |
| FAMILY NAME | Zekri |
| SIGNATURE | ZEKRI A R N |
| AFFILIATIONS | National Cancer Institute |
| ORCID | 0000-0003-3939-0416 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2022 |
| LATEST PUBLICATION YEAR | 2022 |
| H-INDEX | 0 |
Impact of HCV ns5a resistance associated substitutions on treatment outcome of chronic HCV in daclatasvir-based antiviral regimens
Background: RASs have direct relation to the treatment outcome in chronic HCV patients receiving DAAs. Aim and objectives: to evaluate prevalence of NS5A HCV RASs and their impact on the treatment outcome in daclatasvir-based antiviral regimens in a cohort of Egyptian patients. Subjects and methods: This study was conducted on 40 Egyptian chronic HCV patients at the virology unit of Cairo Fatemya hospital. The study participants were recruited fr…
Cairo University fibrosis index (Cufi)
Introduction: Identification of HCV- induced liver fibrosis is mandatory for tailoring therapy, and management of complications. The current study evaluated the accuracy of circulating miRNAs; in diagnosis of hepatic fibrosis. Patients and methods: Seventy HCV patients were subjected to routine laboratory investigations, HCV-RNA, serum miRNA-122, 221, 192, 224 , 375, and 885 by PCR, liver biopsy and calculation of the following scores: aspartate …
No prominent works on this page.
Impact of HCV ns5a resistance associated substitutions on treatment outcome of chronic HCV in daclatasvir-based antiviral regimens
Background: RASs have direct relation to the treatment outcome in chronic HCV patients receiving DAAs. Aim and objectives: to evaluate prevalence of NS5A HCV RASs and their impact on the treatment outcome in daclatasvir-based antiviral regimens in a cohort of Egyptian patients. Subjects and methods: This study was conducted on 40 Egyptian chronic HCV patients at the virology unit of Cairo Fatemya hospital. The study participants were recruited fr…
Cairo University fibrosis index (Cufi)
Introduction: Identification of HCV- induced liver fibrosis is mandatory for tailoring therapy, and management of complications. The current study evaluated the accuracy of circulating miRNAs; in diagnosis of hepatic fibrosis. Patients and methods: Seventy HCV patients were subjected to routine laboratory investigations, HCV-RNA, serum miRNA-122, 221, 192, 224 , 375, and 885 by PCR, liver biopsy and calculation of the following scores: aspartate …
Gastroenterology (2 works) · Hepatitis C virus research (2 works) · Internal Medicine (2 works) · Liver Disease Diagnosis and Treatment (2 works) · Medicine (2 works) · Bilirubin (1 work) · Biopsy (1 work) · Cirrhosis (1 work) · Cohort (1 work) · Daclatasvir (1 work)